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Abstract: The Neem tree, Azadirachta indica A. Juss., is known for its large spectrum of compounds
with biological and pharmacological interest. These include, among others, activities that are
anticancer, antibacterial, antiviral, and anti-inflammatory. Some neem compounds are also used as
insecticides, herbicides, and/or antifeedants. The safety of these compounds is not always taken into
consideration and few in vivo toxicity studies have been performed. The current study is a literature
review of the latest in vivo toxicity of A. indica. It is divided in two major sections—aquatic animals
toxicity and mammalian toxicity—each related to neem’s application as a pesticide or a potential
new therapeutic drug, respectively.
Keywords: toxicity; in vivo; Azadirachta indica
1. Introduction
Throughout time, plants have played an important role in treating different human
diseases. Several plant species have, in one or more of its organs, substances that can
be used for therapeutic purposes. According to the World Health Organization (WHO),
these are called medicinal plants [1]. Azadirachta indica, commonly known as neem, an
evergreen tree of the Meliaceae family, native from India, has been used for thousands of
years in traditional systems of medicine, such as Ayurveda. From the various parts of neem,
including leaves, bark, seeds, flowers, fruits, and roots, a large number of phytochemicals
with different biological and pharmacological attributes, such as azadirachtin, nimbolide,
gedunin, azadirone, salannin, and others, can be extracted [2–6]. These pharmacological
activities include, but are not limited to, anticancer, antibacterial, antifungal, antiviral,
antileishmanial, anthelmintic, antimalarial, antipyretic, analgesic, anti-inflammatory, an-
tidiabetic, antiallergenic, neuroprotective, cardioprotective, and pesticidal activities [4–6].
Due to its therapeutic characteristics, the neem tree is also known, especially in India, as a
“village pharmacy” [7] and was declared by the United Nations as “The tree of the 21st
century” [8]. Although various parts of neem have an extensive use in traditional systems
of medicine [4], the measurement of toxicities of its natural compounds is crucial before its
application as a therapeutic drug [9]. Studies based on animal models confirmed that, at
certain dosages, neem is safe, but on another hand, neem and its compounds may show
toxic/adverse effects [9]. The safety of neem as a pesticide, and of its derivatives, also
represents an important issue and was previously reviewed by Boeke et al. [10].
The present review aimed to provide a state-of-the-art analysis about A. indica’s
in vivo toxicity, focusing on the safety evaluation in aquatic animals and mammalians. This
manuscript represents, to our knowledge, an updated review on this topic.
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2. Safety Evaluation
2.1. Aquatic Animals Toxicity
The contamination of aquatic environments represents a cause for concern. Its evalu-
ation uses different methodologies based on several bioindicators, such as invertebrates,
fish, and algae [11]. The use of invertebrates for toxicity tests presents some advantages
as it reduces the number of mammals and space required, thus becoming less expensive.
These organisms may also provide initial information on the pharmacologic applicability
of nanoplatforms for drug delivery [12]. Fish models, namely the most commonly used
zebrafish, are also easy to obtain, maintain, and reproduce in the laboratory [13]. Inverte-
brates present a limitation, as they have a different biological organization level relative
to mammals and, so, their use should be considered as a prescreening method [14]. This
limitation does not extend to fish models, as they are vertebrate and, thus, share basic
nervous system organization with other vertebrates, such as humans [15].
2.1.1. Acute Toxicity
Saravanan et al. [16] evaluated the acute toxicity of aqueous extracts of A. indica leaves
in fish, Cirrhinus mrigala. Different doses of extract were used (0.25, 0.50, 0.75, 1.0, 1.25,
1.50 ppm) and, for each, ten fish were introduced and kept in separate glass tanks. Mortality
was recorded after 24 h and the half maximal lethal concentration (LC50) value obtained
was 1.035 ppm. Behavioral changes were also observed, such as hypersensitivity, erratic
swimming, abundant secretion of mucus, air gulping, and loss of reflex [16]. Changes in
hematological, ionoregulation, biochemical, and enzymological parameters of fish were
also observed. Mwangi et al. [17] determined the safety of A. indica root bark aqueous
extract using the Brine shrimp lethality test by exposing Artemia salina L. nauplii to different
concentrations of the extract (10, 100, and 1000 µg/mL) for 24 h. The extract was considered
moderately toxic, as LC50 obtained was 285.8 µg/mL. Zebrafish embryo toxicity to A. indica
green callus methanolic extract was carried out by Ashokhan et al. [18], using six different
concentrations ranging from 500–5000 µg/mL for 5 days. After treatment, LC50 value
was determined to be 4606 µg/mL and the extract was considered nontoxic. Besides,
zebrafish embryos treated with concentrations below 4000 µg/mL were able to hatch into
larvae, while embryos treated with 5000 µg/mL presented a 0% hatching rate. Zebrafish
larvae also presented a normal heart rate (136 beats/min) and no teratogenic defects were
observed in embryos or larvae [18]. According to this study, green callus, obtained from
A. indica leaf, has the potential to produce an environmentally and sustainable friendly
pesticide.
Acute effects of commercial neem insecticides, Azatin (containing 3% azadirachtin
(AZA)) and Neemix 4.5 (containing 4.5% of azadirachtin and 3–5% of neem oil), on Daphnia
pulex were evaluated by Stark [19]. The aquatic invertebrates were exposed to different
concentrations of each product for 48 h. The LC50 values obtained were 0.57 mg AZA/L
(concentration based on azadirachtin equivalence) and 0.68 mg AZA/L for Azatin and
Neemix, respectively, thus considered equitoxic. Acute toxicity of the other two neem-
based insecticide, NeemixTM (0.25% AZA) and BioneemTM (0.09% AZA), and pure AZA,
were also determined for D. pulex [20]. The water fleas were exposed, for 48 h, to different
concentrations of each compound (ranging between 0 to 0.5 µg AZA/mL) and the LC50
value was determined at the end of this period. Of the three compounds tested, BioneemTM
presented the lowest LC50, 0.03 µg AZA/mL, followed by NeemixTM, 0.07 µg AZA/mL,
and AZA with 0.382 µg/mL. Therefore, BioneemTM was the most toxic compound for D.
pulex on this study [20]. Goktepe and Plhak [20] also evaluated the acute toxicity of AZA,
NeemixTM, and BioneemTM on Procambarus clarkii. This species was exposed to different
concentration of each compound for 96 h. This crustacean was less sensitive to both
pesticides (LC50 of 4.71 and 6.60 µg AZA/mL for NeemixTM and BioneemTM, respectively)
than to pure AZA (LC50 > 1 µg/mL). The acute toxicity of these pesticides was also studied,
after 96 h of exposure, in other crustaceans, such as Penaeus setiferus, Palaemonetes pugio, and
Callinectes sapidus [20]. From these, P. pugio was the least sensitive to both compounds (LC50
Molecules 2021, 26, 252 3 of 21
of 3.19 and 3.81 µg AZA/mL for BioneemTM and NeemixTM, respectively), followed by P.
setiferus and C. sapidus, with LC50 of 2.68 and 1.15 µg AZA/mL for NeemixTM, respectively.
These authors [20] also used the third instar larvae of mosquitoes (Culex quinquefasciatus) to
test the acute toxicity of NeemixTM and BioneemTM in a 96 h exposure test. Both pesticides
had strong toxicity against these larvae, with LC50 values of 0.57 and 0.14 µg AZA/mL
for BioneemTM and NeemixTM, respectively. The acute toxicity of BioneemTM was also
tested on Ceriodaphnia dubia by Botelho et al. [21]. The animals were exposed to different
concentrations of the product (0.01, 0.1, 1, and 10 mL/L) for 48 h. After that, the LC50
calculated was 0.032 mL/L, revealing toxicity to the organisms tested.
Pereyra et al. [22] tested the toxicity of Neem’s solution (a mix of 60% pure neem’s
oil and 40% fatty ethoxylated alcohol of 9 mols as emulsifier) against Limnoperna fortune
(larvae and adults), Daphnia magna, and Cnesterodon decemmaculatus. All tests were made
with at least five concentrations (not specified) and one control. In the case of D. magna, the
animals were exposed for 48 h and the LC50 value obtained was 17 µL/L. C. decemmaculatus
were exposed to Neem’s solution for 96 h and the LC50 value reported was 4.92 µL/L. For
the toxicity of L. fortune, larvae and benthonic adults (7, 13, and 19 ± 1 mm) were used and
mortality was checked after 72 h. Larvae were more vulnerable to the toxicity than adults,
and presented a LC50 value of 8 µL/L. The LC50 of adults changed with their size, 241, 249,
and 122 µL/L for 7, 13, and 19 mm length, respectively. From the different species used in
this study, adults of L. fortune were the least sensitive to Neem’s solution [22]. Thus, when
used as a pesticide in agriculture, Pereyra et al. [22] recommended that it should not be
used in open waters, but only in closed systems, in man-made facilities.
The acute toxicity of Bioneem oil (90% neem oil and 10% emulsifiers and synergetic
ingredients) was tested against D. magna and D. rerio, for 48 and 96 h of exposure, respec-
tively [23]. In the case of D. magna, the organisms were exposed to different concentrations
of Bioneem oil, 0.015, 0.031, 0.065, 0.125, 0.250, 0.50, 1.0, 2.0 mL/L, and the median effective
concentration (EC50) for immobility was determined, 0.17 mL/L. For D. rerio, the concentra-
tions used were 0.16, 0.2, 0.32, 0.4, and 0.8 mL/L and LC50 value obtained was 0.22 mL/L.
Maranho et al. [23] concluded that D. magna had higher sensitivity to the bio-insecticide
studied than D. rerio.
2.1.2. Chronic Toxicity
Botelho el al. [21] studied the chronic toxicity of BioneemTM in C. dubia. These animals
were exposed to different concentrations of the product (0.001, 0.002, 0.004, 0.008, and
0.016 mL/L) for 7 days. After this period, a decrease in the number of neonates per female
at higher concentrations was observed. Thus, BioneemTM presented a toxicity effect in the
reproduction of C. dubia. Maranho et al. [23] evaluated the chronic toxicity of Bioneem oil in
D. magna. In a 21-day assay, five different concentrations were used, 0.0106, 0.0212, 0.0425,
0.0850, 0.17 mL/L, and, at the end of the test, the average number of neonates produced
and the sizes of adult organisms were compared between the control and treatments. This
chronic test revealed some Bioneem oil effects, such as reduced number of neonates and
inhibition of size. It was also possible to observe that means of both parameters were
significantly lower when compared to the control, consequently revealing a toxic effect [23].
Taking these results into consideration, and also the ones obtained from the acute toxicity
tests, Maranho et al. [23] concluded that even at low concentrations Bioneem oil may cause
adverse effects to aquatic organisms.
2.1.3. Genotoxicity
The genotoxic effects of azadirachtin were assessed in fish, Oreochromis mossambicus, by
Chandra and Khuda-Bukhsh [24]. Animals were injected intramuscularly, with 0.005% of
azadirachtin at 1 mL/100 g body weight (b.w.), kept separately, and fed with a standard diet
until sacrificed (6, 24, 48, 72, and 96 h after treatment). Somatic metaphase complements
were carefully observed for any structural and numerical alteration and, as result of the
treatment, changes were detected, such as break, terminal association, centric fusion, preco-
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cious centromeric separation, and C-mitosis [24]. In terms of proteotoxicity, azadirachtin
treatment drastically reduced the number of protein bands (on electrophoretic gel), par-
ticularly in tissues such as kidney, dorsal muscle, and gill. Quantitatively, azadirachtin
also induced changes in the protein content of tissues, such as kidney, liver, and spleen
(mild changes) and gill and heart (drastic changes). Thus, Chandra and Khuda-Bukhsh [24]
suggested that the use of this natural product, azadirachtin, should be viewed with caution.
It is important to note that in real conditions, other chemical and microbial activities
would also influence the effect of such compounds/pesticides [20]. Table 1 summarizes the
different studies of toxicity of neem using different aquatic animals. In most studies acute
toxicity assays were performed and neem pesticides or derivatives were tested. Concluding
from these studies, neem extracts presented the lowest toxicity in acute tests. Chronic and
genotoxicity assays revealed toxicity to the animals tested.
2.2. Mammalian Toxicity
These animal models have the advantage of sharing certain characteristics with hu-
mans, which are lacking in some other models, such as placentation, development in utero,
and maternal/fetal metabolism and interactions [25]. The mammalian models organisms
mainly include mice, rats, and rabbits.
2.2.1. Acute Toxicity
Aqueous extracts of A. indica leaves were evaluated for acute toxicity by Dorababu
et al. [26]. This study was carried out in mice, using different doses of extracts (200, 500,
1000, and 2500 mg/kg b.w.) and observing the animals for 24 h. No mortality was observed
and the median lethal dose (LD50) value was considered higher than 2500 mg/kg. A similar
study was performed by Kingsley et al. [27], who orally administrated different doses of
aqueous extracts of A. indica to mice (1250, 2500, and 5000 mg/kg b.w.). No obvious toxic
side effects were observed and treated mice were found healthy and normal with no record
of weight or hair loss, allergy, or other symptoms of discomfort. Thus, the LD50 value was
considered higher than 5000 mg/kg. The acute toxicity of aqueous extracts of A. indica
leaves and seeds were tested in rats at different concentrations, 0.05, 0.071, 0.084, 0.092, and
0.1 g/mL and 0.1, 0.15, 0.17, and 0.2 g/mL, respectively [28]. The study was performed for
2 days by intramuscular injection of the animals with the different concentrations of the
extracts (0.07 mL/g b.w.). Aqueous extracts of leaves and seeds presented a LD50 value of
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A suspension of ethanolic extract of A. indica leaves was orally administered at 5 g/kg
b.w. dose to mice, for 7 days [29]. No acute toxicity manifestation or death were observed,
thus the LD50 value was considered higher than 5 g/kg. Kanagasanthosh et al. [30] also
evaluated the acute toxicity of ethanolic extract of A. indica leaves, but for 14 days in rats.
During treatment, oral doses of 20, 200, or 2000 mg/kg b.w. of extract were administered
to the animals. After treatment, no significant changes were observed in the behavioral or
autonomic responses of the animals, and no mortality was registered. Thus, the LC50 was
considered higher than 2000 mg/kg b.w. Achi et al. [31] orally administered different doses
of ethanolic extracts of A. indica leaves to mice (50 to 5000 mg/kg b.w.) and observed them
for 1 day. No mortality occurred, so LD50 was considered higher than 5000 mg/kg and the
extract was considered safe. A similar assay was performed by Oseni and Akwetey [32]
and LD50 value was considered higher than 1000 mg/kg. Recently, similar results were
obtained by Tepongning et al. [33], who evaluated the acute toxicity of hydroethanolic
extracts of A. indica leaves using rats. During 14 days, oral doses of 2000 and 5000 mg/kg
b.w. of extract were administered and LD50 was considered higher than 5000 mg/kg b.w.,
as no significant behavioral changes or morbidity/mortality were observed [33]. Thus, it
was classified as practically nontoxic and without any risk to human health. During these
14 days of testing, the animal body weight did not significantly increase, with a maximum
weight gain of 2.6 g for the treated groups compared to 2.7 g in the control group. Akin-
Osanaiye et al. [34] administered, to mice, methanolic extract of A. indica leaves at doses of
10, 100, and 1000 mg/kg b.w., via the intraperitoneal route, and observed the animals for
signs of toxicity and death for 24 h. Animals exhibited slow movement within the first six
hours of administration and, after 24 h, concentrations of 100 and 1000 mg/kg of extract
produced mortality. The LD50 obtained was 31.62 mg/kg and the extract was classified as
highly toxic [34].
Acute toxicity tests of crude ethanolic extracts of A. indica stem bark were carried out
in rats by Mbaya et al. [35]. The animals were treated intraperitoneally with graded doses
(100, 200, 400, 800, 1600, 3200, and 64,000 mg/kg b.w.) and observed for 24 h. Animals
administered with the three highest doses manifested clinical signs such as depression, de-
hydration, malaise, anorexia, respiratory depression, coma, and death, with the symptoms
being dose related. The LC50 value calculated was 870 mg/kg. Stem bark extracts were
also tested by Akin-Osanaiye et al. [34], but in mice. In their study, methanolic extracts
of this part of A. indica were administered at doses of 10, 100, and 1000 mg/kg b.w., via
the intraperitoneal route, and the animals were observed for signs of toxicity and death
for 24 h. The LD50 value obtained was 489.90 mg/kg and the extract was classified as
moderately toxic [34].
The acute toxicity of another part of A. indica, flowers, has also been tested in rats.
Kupradinum et al. [36] orally administered different concentrations of methanolic extracts
of A. indica flowers (6, 9, and 12 g/kg b.w.) for 14 days, and no signs or symptoms of
toxicity were observed. Thus, the LD50 was considered higher than 12 g/kg.
Neem oil acute toxicity was determined by Deng et al. [37] in a 14-day assay. In this
study, mice were orally treated with neem oil mixed with 1% carboxymethyl cellulose at
the doses of 18.40, 23.00, 28.80, 36.00, and 45.00 g/kg. In each case, the product volume
administered by gavage was 2 mL/100 g b.w. Fifty minutes after treatment, mice treated
with higher doses appeared to move slowly, were very sensitive to noise, and got chills
and convulsions. Death necropsy revealed a lot of liquid filling and intestinal swelling in
the guts of mice, while other tissues and the organs showed no obvious abnormalities. The
LD50 value obtained was 31.95 g/kg and Deng et al. [37] classified the neem oil as not toxic.
A study based on rabbits was performed to check the toxicological analysis of aqueous
extract of A. indica leaves [38]. Extracts were administered orally daily, by gavage, to rabbits
for 14 days at dose levels of 5 or 24 mg/kg b.w. No signs of toxicity were observed, although
animals became dull and lost appetite. A progressive increase in body weight, in both test
and control animals, was observed. No acute toxic effect was observed on hematological
and biochemical parameters, and gross and histopathological lesions detected did not
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reveal any significant pathology to any of the organs. Boadu et al. [38] considered 2.5 mg/kg
the no-observed-adverse-effect-level (NOAEL) of crude aqueous extract of neem leaves in
rabbits.
Table 2 summarizes the different studies of acute toxicity of neem in mammals. It
can be said that the acute toxicity of neem is more related to the mode of administration
of the extract/sub product, than to the part of the plant, extract, and/or concentration.
Animals only revealed acute toxicity when treated by intramuscular injection or via the
intraperitoneal route. When treated orally, no significant changes or toxicity were recorded.
2.2.2. Subacute Toxicity
Dorababu et al. [26] studied the subacute toxicity of aqueous extracts of A. indica leaves,
at 1000 mg/kg b.w., by giving it orally to rats for 28 days. After treatment, no mortality
was registered, nor histological changes in the kidney, liver, testis, or adrenals, but their
weights increased or tended to increase. In additional, hematological parameters and liver
and kidney function tests revealed few or no change from the control values, indicating A.
indica leaf extract as a safe drug. Haque et al. [39] tested the toxicity of aqueous extracts
of A. indica, in what they called neem leaf preparation (NLP). According to these authors,
extracts obtained from 0.25, 0.5, and 1 mg of dry neem powder were considered as 0.5, 1,
and 2 units of NLP, respectively. Mice were treated with 0.5, 1, or 2 units of NLP weekly
for 28 days. After treatment, no mortality occurred at the lowest tested concentrations.
However, at 2 units of NLP, the mice’s survival was 83% and 66% after second and third
week of treatment, respectively. Surviving mice, of all tested concentrations, showed no
significant changes in physical behavior, body weight, or organ to body weight ratio. NLP
treatment stimulated hematological systems, as evidenced by the increase in total count
of red and white blood cells, platelets, and hemoglobin percentage. Due to their results,
Haque et al. [39] considered NLP as of nonhepatotoxic nature. Mallick et al. [40] evaluated
the toxicological profile of neem leaf glycoprotein (NLGP) in both mice and rats. Different
doses of NLGP (25, 50, 100, and 200 µg) were weekly injected in the animals for four weeks.
No death nor behavioral changes were observed in any animal, as well as no significant
changes in body or organs weight. Besides, injected mice showed more stretching and/or
jumping gestures that the control mice, without being considered hyperactive. Both
histological evaluation of brain, kidney, lung, liver, spleen, and lymph nodes and the
hematological profile of injected animals were normal. Kidney and liver functions were
not affected. Additionally, a small hematostimulation was noticed, as shown by increased
hemoglobin content, lymphocyte numbers, and leukocyte count. In both mice and rats,
no apoptotic effect on immune cells was observed, but NLGP induced proliferation of
mononuclear cells collected from the animals. This study, also confirmed that NLGP had
no killing effect on immune cells and it maintained the immune functions in activated state,
but not hyperactivation [40].
The subacute toxicity of ethanolic extracts of A. indica leaves were tested for 28 days,
with oral doses of 75, 150, and 300 mg/kg b.w. daily administrated [33]. No changes were
observed in the animals during treatment and the rats grew normally, in both treatment
and control groups, with a total weight gain of approximately 10 to 20 g. The biochem-
ical parameters profile, after treatment, revealed no significant changes (p > 0.05), with
the exception of the aspartate amino transferase (ASAT) level of animals treated with
300 mg/kg b.w., which increased when compared to the control, 213.58 and 153.85 U/L,
respectively [33]. This suggests muscular dysfunction or damage to internal organs, which
was confirmed by autopsy of the animals on day 28. A general darkening of the liver
with the presence of nodules in animals treated with extracts at 300 mg/kg b.w., and the
presence of lung nodules in one animal treated with extract at 150 mg/kg b.w., compared
to the controls, was observed [33]. Although, no differences in weights of organs such as
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Ethanolic extract of A. indica stem bark at 50, 100, 200, and 300 mg/kg b.w. was
orally administered to rats for 21 days [41]. After treatment, and specially at higher
doses, the levels of white blood cells, platelets, serum triacylglycerol, and high-density
lipoprotein cholesterol decreased significantly (p < 0.05). Although, the final body weights;
absolute weights of the heart, lungs, liver, and kidney; organ–body weight ratios; total
and conjugated bilirubin; low-density lipoprotein cholesterol; serum globulins; serum
cholesterol; and computed atherogenic index increased significantly (p < 0.05). Changes
in spleen–body weight ratio, alanine and aspartate transaminases, alkaline phosphatase,
calcium, sodium, potassium, and food and water intake were also observed at specific
doses. According to Ashafa et al. [41], only the dose of 50 mg/kg b.w. appeared to be
relatively safe.
Bansod et al. [42] found no significant changes in body and pancreas weight and
plasma biomarker levels in mice treated with nimbolide when compared to the control.
In this study, mice received 1 mg/kg b.w. of nimbolide, per day, for 21 days. The com-
pound was dissolved in dimethyl sulfoxide and intraperitoneally injected. The treatment
also did not cause alterations in oxidative stress parameters, such as malondialdehyde,
glutathione, and nitrite levels, as well as any changes in cytokines levels. After treatment,
the architecture of pancreatic tissue was considered normal.
The subacute oral toxicity of neem oil was evaluated over 28 days by Deng et al. [37].
During this time, mice received a daily dose of 177, 533, or 1600 mg/kg b.w. After treatment,
no death or effects on body weight were observed, as well as no significant differences,
compared to the control, on serum biochemistry parameters of mice (p > 0.05). Also, the
organ coefficient of liver, heart, lung, kidney, and spleen in treated mice presented no
statistical difference compared to those of the control group (p > 0.05). Although, mice
treated with a higher dose (1600 mg/kg) showed treatment-related clinical signs, such
as loss of appetite and rough fur in the last 2 weeks, and histopathological examination
revealed this dose had varying degrees of damage on kidneys, liver (consistent changes in
both sexes of mice), and testicles.
Table 3 summarizes the different studies of subacute toxicity of neem. It can be
inferred that the subacute toxicity of neem is more related to the concentration tested, as
higher concentrations seem to be more toxic, than to the mode of administration of the
extract/subproduct or part of the plant and/or extract. In general, subacute toxicity or
significant effects were observed in animals treated with higher concentrations of the neem
extract/subproduct.
2.2.3. Subchronic Toxicity
Rahman and Siddiqui [43] studied the biochemical effects of vepacide on rats during
subchronic exposure. Vepacide is a neem-based-pesticide, obtained by the isolations of a
free-flowing solid from seed kernels of A. indica. Different doses of Vepacide in coconut
oil (80, 160, and 320 mg/kg b.w.) were orally administered for 45 or 90 days. During
treatment (45 days) and at the end of the treatment (90 days), an increase in acid (AcP)
and alkaline (AkP) phosphatase in serum, kidney, lung, and liver tissue (AkP only in
liver) and a decrease of AcP in liver were observed in cases where moderate and high
doses were used. These changes were dose- and time-dependent and indicated that lung
tissue was the most susceptible, followed by liver and kidney [43]. Although, 28 days
post-treatment (withdrawal study) animal recovery was observed, indicating reversal of
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Kupradinum et al. [36] fed rats with methanolic extract of A. indica flowers in 0.5%
tragacanth daily for 90 consecutive days at the doses of 150, 750, and 1500 mg/kg b.w.
After treatment, growth rate of male rats was affected, but no differences were recorded
in both male and female rats’ weights. Histopathological examination of visceral organs
also showed no change and blood chemistry values of most animals were within normal
ranges. Although, in high-dose male rats, the levels of aspartate aminotransferase and
blood urea nitrogen were significantly lower and creatinine was higher than in control rats.
Alkaline phosphatase, creatinine, and potassium values were significantly higher in the
female group receiving 750 mg/kg b.w. dose. Kupradinum et al. [36] concluded that the
extract tested showed slight toxicity to rats at doses greater than 150 mg/kg/day.
Wang et al. [44] studied the subchronic toxicity of neem oil in mice, in order to
determine the NOAEL of exposure and target organs of neem oil. For 90 days, neem oil
was daily orally administered to mice in different doses, 177, 533, or 1600 mg/kg b.w. After
treatment, no death or effects on body weight were observed, as well as no significant
differences, compared to the control, on serum biochemistry parameters of mice (p > 0.05).
Also, the organ coefficient of liver, heart, lung, kidney, and spleen in treated mice presented
no statistical difference compared to those of the control group (p > 0.05). Although, mice
treated with higher doses (1600 mg/kg) showed treatment-related clinical signs, such
as loss of appetite and rough fur in the last 2 weeks, with very significant decreased in
months two and three (p < 0.01). The histopathological examination revealed that this dose
had varying degrees of damage on each organ except heart, uterus, and ovary (consistent
treatment-related histopathological changes in both sexes). The damages observed were
restored after the discontinuation of treatment for 30 days. Wang et al. [44] considered
177 mg/kg the NOAEL and that the target organs of neem oil toxicity were the kidneys,
liver, and testicles.
Table 4 summarizes the three studies of subchronic toxicity of neem. It reveals that
the subchronic toxicity of neem was dose dependent, higher concentrations were revealed
to be more toxic, and its effects could be reversed after treatment discontinuation [43,44].
Table 4. Subchronic toxicity of neem in different mammalians.
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2.2.4. Reproduction and Teratogenicity
Ghodesawar et al. [45] orally administered, to male rats, 100 mg of A. indica leaf
powder in 1 mL of distilled water, every day, for 24 days, in order to elucidate its effect
on the ultrastructural organization of the epithelial cells of cauda epididymis. Several
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ultrastructural changes were observed, indicating that the principal cell and the clear cell
were affected, thus altering the composition of epididymal fluid, which may cause sperm
mutations. A similar study was carried out by Aladakatti and Ahamed [46], who orally
administered, to male rats, 100 mg of A. indica leaf powder in distilled water, every day,
for 48 days, in order to detect changes in Sertoli cells. After treatment, bridges between
Sertoli cell–germ cells and Sertoli cells–Sertoli cells were disturbed, coupled with changes
in the Sertoli cells and cytoplasm, along with its organelle, such as damaged tubules and
abundance of vacuoles.
Aladakatti et al. [47] orally administered different concentrations of aqueous extracts
of A. indica leaves (125, 250, and 375 mg/kg b.w.) to male rats for 24 days. Dose-related
effects on biochemical parameters of testis and epididymis were reported, suggesting that
A. indica leaf extract has one or more constituents that may affect the androgen synthesis
and, thus, exhibit antiandrogenic effects on androgen-sensitive target glands, such as testis
and epididymis [47]. In order to determine whether aqueous extract of A. indica leaves
induces generation of reactive oxygen species (ROS) and apoptosis through mitochondria-
mediated pathway in rat oocytes, sexually immature female rats were fed palatable doses
of extract (10 mg/g dry feed palate) for 10 days [48]. After that, rats were subjected to
superovulation induction protocol. After treatment, morphological apoptotic changes were
observed, associated with increases in hydrogen peroxide, nitric oxide, and cytochrome
c concentrations; caspase-9 and caspase-3 activities; and DNA fragmentation in oocyte.
Thus, the extract induces ROS generation leading to oocytes apoptosis via a mitochondria-
mediated pathway.
Ethanolic extract of A. indica leaves at different concentrations, 65, 135, and 200 mg/kg
b.w., were orally administered to female rats during the 4th, 5th, and 6th day of pregnancy
and after birth (lactating females) for 15 days [49]. After treatment, there were no signs
of systemic or reproductive toxicity, such as weight loss, diarrhea, ataxia, piloerection,
stereotypes, vaginal bleeding, coma, or death. No neonatal malformation was observed
upon external examination of the offspring from the control or experimental groups. The
development of the nervous system and physical development of the offspring was not
affected, as well as the body mass weight. Thus, the extract used did not cause any
systemic toxicity, nor induced teratogenicity, being considered safe for use during the pre-
and postnatal period in rats [49].
Terpenoid extract from the leaves of A. indica was orally administered to pregnant
rabbits at 300 mg/kg b.w. (per day), for 11 days, starting from day 14 of the gestation
period of the animals [50]. Lead acetate (50 mg/kg b.w.) was also administered to each
animal after the extract. The results reported showed that terpenoid extract was well
tolerated by pregnant animals, as no death, abortion, or stillbirth were observed. Also,
the litters did not show any deformity or malformation. The animals pretreated with the
extract had no statistically significant difference in lead concentration when compared to
the lead-only treated group. Thus, Babalola and Areola [50] concluded that the terpenoid
extract was nonembryotoxic, nonteratogenic, and nonabortifacient, but had no ability to
interfere with lead from crossing the placenta and to reduce lead burden in the pregnant
rabbits.
Raji et al. [51] studied the effect of methanolic extract of A. indica stem bark in male
rats. Some animals were treated daily, by gavage, with 150 mg/kg b.w. of the extract and
others with the same amount of extract plus vitamin E (100 mg/kg b.w.), both for 45 days.
After treatment, there was no significant change in body and organ weights, nor in sperm
volume of the animals treated with the extract, compared to the control. However, there
was a significant decrease (p < 0.05) in sperm viability, serum testosterone level, and on
lipid peroxidation and superoxide dismutase activity. In this study, it was also reported
that vitamin E had a positive impact in the adverse effect caused by A. indica stem bark
extract.
Ethanolic extract of A. indica seed was orally administered to rats at a 200 mg dose,
in order to study its effect on estrous cycle, ovulation, and fertility [52]. For that, one
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group of animals was treated with extract dose for 3 weeks, another at 9 a.m. and at 6 p.m.
on proestrus and on the morning of estrus, and another on day 1 to 5 postcoitum. After
treatment, rats showed alterations in the estrous cycle, particularly a prolonged diestrus
pattern and a partial block in ovulation. However, no anti-implantation/abortifacient effect
was observed, as well as no teratogenicity in the fetuses. Seed extract of A. indica was also
tested for its effect on follicular development in cyclic female albino rats by Roop et al. [53].
Polar and nonpolar fractions of the extract were orally administered at 3 and 6 mg/kg
b.w. to the animals for 18 days. Results showed, for both fractions, a significant reduction
(p < 0.05) in the number of normal single-layered follicles, follicles in various stages (I-VII)
of follicular development, and total number of normal follicles. A similar study was carried
out by Gbotolorun et al. [54], but using ethanolic extract of A. indica flowers. In order
to analyze the effect on estrous cycle, rats received 1 g/kg b.w. of extract by gavage for
21 days. For the study of the effect on ovulation, one group of rats received 1 mg/kg b.w.
of flower extract orally at 9 a.m. on proestrous and another group at 6 p.m. on proestrous.
To understand the effect on fetus, one group of rats received 1 mg/kg b.w. of extract by
gavage from day 1 to 5 postcoitum. After treatments, all animals fed with the extract had
diarrhea and a 6.46% decrease in body weight. Eighty percent of the rats form the estrous
cycle group test presented an irregular pattern of this cycle and also a prolonged diestrus
pattern in each cycle. The effect on ovulation was only detected in the group of rats who
received the extract at 9 a.m., with reduction in the number of ova shed in the oviduct. In
this study, either pregnancy or the offspring were affected by the A. indica flower extract.
Different doses of aqueous wood ash extract of A. indica, 5, 50, and 100 mg/kg b.w.
were orally administered to male rats in order to evaluate its reproductive toxicity [55].
Results showed no toxic effect on testicular weight and hormones (testosterone, follicle-
stimulating hormone, and leuitinizing hormone). However, a significant decrease (p < 0.05)
in sperm count, sperm motility, and live/dead sperm, as well as a significant increase
(p < 0.05) of abnormal sperm were registered, which indicates that infertility occurred. The
extract also presented toxic effect on spermatogenesis, proven by the histopathological
changes in the testis observed, such as numerous apoptotic cells, vacuolation, and necrosis
of the late elongated spermatids and seminiferous tubules with formation of multinucleated
giant cells.
Srivastava and Raizada [56] reported absence of any major adverse reproductive
effects in adults rats, as well as in 21-day-old pups of F2B generation. In this study, the
female rats were fed 100, 500, and 1000 ppm technical azadirachtin through diet, which
is equivalent to 5, 25, and 50 mg/kg b.w. No toxicological effect was reported for parent
rats or teratogenic effects in the F1 and F2 generations. There was also no evidence of
cumulative effects on postnatal development and reproductive performance over two
generations.
Dallaqua et al. [57,58] performed different studies in order to assess the effects of A.
indica on lipid profile, oxidative stress status, and glycemic status in both nondiabetic and
mildly diabetic pregnant rats [57] and on the frequency of congenital malformations in
fetuses from pregnant rats [58]. In both studies, animals were treated with either neem seed
oil (1.2 mL/day) or azadirachtin (1.0 mg/mL/day), orally administered throughout preg-
nancy for 21 days. In the first study [57], the treatment with azadirachtin and neem seed oil:
(i) did not affect the lipid profile in nondiabetic dams; (ii) increased the proportion of fetuses
classified as small for pregnancy age; (iii) had no hypoglycemic and anti-hyperglycemic
effects on nondiabetic and diabetic rats, respectively; (iv) interfered with oral glucose test
tolerance glycemic levels in diabetic rats; and (v) increased lipoperoxidation, characterized
by increased malonaldehyde levels in nondiabetic rats. In the second study [58], no sig-
nificant changes in glucose levels or total area under the curve were observed in animals
treated with azadirachtin or neem seed oil. Although, an increment on the frequency of
malformation/variation, in particular the visceral in fetuses, was shown in animals treated
with neem seed oil. Thus, when administered during pregnancy, neem seed oil caused
abnormalities in rat fetuses, showing a teratogenic effect [58], and both neem seed oil
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and azadirachtin impaired intrauterine development and altered antioxidant/oxidative
status [57]. Another study evaluated the toxic and teratogenic, short- and long-term, effects
on fetuses and pups of different doses (0.90, 1.80, 3.0, 9.0, and 45.0 mg/kg) of azadirachtin
of neemix-4.5 (neem-based insecticide), orally administered on days 7–12 of gestation or
during an 80-day period in pregnant mice [59]. No morphological or skeletal changes were
produced in fetuses and pups.
Aladakatti et al. [60] daily administered subcutaneously, to male albino rats, differ-
ent doses of azadirachtin-A (0.5, 1.0, and 1.5 mg/kg b.w.) for 24 days. After treatment,
no significant differences were observed in animals’ body weight. However, the higher
dose provoked a general decrease in reproductive organs weights, changes in biochemi-
cal parameters, and reduction in the sperm functional parameters, increasing abnormal
sperms. Similar results were obtained in a 24-day assay, where nimbolide was administered
subcutaneously to male albino rats at different concentrations, 0.5, 1.0, and 1.5 mg/kg
b.w. [61]. After treatment, no statistically differences between animals’ body weights were
observed, but their weights of reproductive organs decreased. The treatment also reduced
sperm functional parameters and increased abnormal sperm counting in a dose-dependent
manner. Biochemical analyses revealed a decrease in acid phosphatase and total protein
content, and an increase in the total free sugar and activities of lactate dehydrogenase and
alkaline phosphatase [61].
Table 5 summarizes the different studies of reproduction and teratogenicity of neem.
In the majority of the studies reported, changes were described for both the female and
male reproductive system, namely female and male gametes.
When performing in vivo studies it is important to have in mind that protocols should
minimize the number of animals used, as well as their suffering [62]. Thus, replacing
in vivo studies by in vitro studies should be considered, but these are only relevant if the
cells used represent a target organ for the compound in study, and realistic concentrations
are used. In fact, regarding A. indica, few in vitro studies have been performed. These
included the evaluation of nimbolide, gedunin, and neem oil cytotoxicity on different
normal cell lines. Nimbolide presented no toxicity against RWPE-1 cells, a normal prostatic
cell line [63]; NIH3T3 cells, a mouse embryonic normal fibroblast cell line; and CCD-
18Co cells, a colon normal fibroblast cell line [64,65]. This compound also presented no
significant changes when tested for subacute effects in vivo [42]. Although nimbolide
had some reproductive effects in rats, as abovementioned. In the case of neem oil, two
in vitro studies found no significant effects in NIH 3T3 cells and CCD-18Co [66] cells, nor in
MCF-10A cells—normal human mammary epithelial cells [67]—when low concentrations
were used. The same was observed in the acute, subacute, and subchronic in vivo toxicity
studies abovementioned using neem oil. This only had siginifican effects in high doses
or in the reproduction/teratogenicity studies. Regarding gedunin toxicity, there are no
recent in vivo studies, but low toxicity was described in vitro for adult-derived normal
cells, Hs578Bst cells and human mammary epithelial cells (HMEs) [68], normal pancreatic
cells (hTERT-HPNE) [69], human peripheral blood mononuclear cells [70], and normal
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3. Material and Methods
A literature search using several online databases, such as PubMed, Science Direct,
ISI Web of Knowledge, and Google scholar, was conducted up to October 2020. The
principal search topics were related to A. indica and toxicity: acute toxicity, subacute
toxicity, subchronic toxicity, and chemistry. Secondary searches included articles cited in
sources identified by the previous search.
4. Conclusions and Future Perspectives
From the studies presented and highlighted in this review, it is clear that for aquatic
organisms, neem extracts presented the lowest toxicity, while neem pesticides or derivatives
presented moderate to high toxicity. However, these extracts have been tested only in terms
of acute toxicity, thus chronic studies need to be performed in future. Although only a few
studies on aquatic animals were mentioned, it can be said that the application of neem
commercial pesticides should be handled with care and aqueous neem-based products
should be encouraged.
Due to its pharmacological properties, the safety of A. indica extracts and/or isolated
compounds should be evaluated, especially using mammalian models. Acute and subacute
toxicity screenings of medicinal plants are a rapid way to assess its toxicological profile,
providing an insight on safety/harmful aspects of compounds to evaluate. This paper
reviewed a large number of studies about mammalian toxicity of neem. In terms of acute
toxicity, the mode of administration had an important impact. Neem extracts/subproducts
are nontoxic or less toxic when orally administered. Animals only revealed acute tox-
icity when treated by intramuscular injection or via the intraperitoneal route. In what
concerns subacute and subchronic toxicity, neem extracts/subproducts’ toxicity is dose
dependent. Higher concentrations were revealed to be more toxic regardless of the mode of
administration. In terms of effects on reproduction and teratogenicity, some of the studies
presented reported no effects, but most of them described changes in both the male and
female reproductive systems.
Currently, little information is available on pharmacokinetic profiles (absorption, dis-
tribution, metabolism, and excretion (ADME)) of neem compounds. However, pharmacoki-
netic studies are important as a basis to determine toxicity and perform risk assessments,
because they can provide data about concentrations in target organs and cells, uptake into
blood, and distribution in the body. This represents an important future area of research,
which should obtain ADME data available before toxicity tests. It is also important to keep
in mind that, when performing in vivo tests with animals, the strategy should take into
consideration the 3 R’s—refine, replace, and reduce: use as few animals as possible and
refine the methods to minimize the suffering involved. Whenever possible, consider the
replacement of in vivo studies with in vitro studies in cell cultures. In the particular case
of A. indica, there are only a few studies evaluating its toxicity effects in vitro using normal
cells. This represents a good opportunity for researchers, as further studies need to be
conducted.
In conclusion, neem extracts present no or very low acute toxicity on mammalians.
Subacute and subchronic toxicity on these animals can be eliminated if lower doses are
used. Thus, due to these safety characteristics and their well-known pharmacological
properties, neem tree and its compounds/extracts present a high commercial importance
and can be considered serious candidates to new natural drugs therapies.
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